Search
DarioHealth Corp
DRIOAdd to Watchlist
5.800USD
-0.660-10.22%
Close 10-05 16:00（ET）
56.78MMarket Cap
LossP/E TTM
DarioHealth Corp (DRIO) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to DarioHealth Corp in the past month.
Buy
1 Strong Buy
3 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
13.600USD+110.53%
DRIO Analyst Recommendation Trends
In the current month, DRIO has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. DRIO average Analyst price target in the last month is 13.600.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
3
3
2
2
2
3
2
2
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
4
4
4
5
4
4
DRIO Analyst Rating for Peer Comparison
Updated: Oct 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
12
4
0
0
29
Stryker Corp
SYK
11
13
5
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Abbott Laboratories
ABT
11
13
4
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
10
12
5
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, DRIO EPS is projected to reach -0.655 in FY2026Q3, following reported EPS of -0.848 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-3.24
-1.48
-1.22
-0.66
-0.60
Actual
-4.74
-1.25
-0.85
--
--
Surprise
-46.32%
+15.32%
+30.20%
--
--
FAQs
What is DarioHealth Corp's expected revenue for the next quarter?
DarioHealth Corp's expected revenue is 5.24M.
What is DarioHealth Corp's price target?
Analysts forecast that DarioHealth Corp's price target is USD 13.60, with the highest forecast at USD 28.00 and the lowest forecast at USD 8.00.
How have DarioHealth CorpDRIO's recent earnings per share performed?
The market expectation was USD -0.85, while DarioHealth CorpDRIO's earnings per share (EPS) for the previous quarter was USD -1.25. EPS for the next quarter is expected at USD -0.66.
What is the analyst rating for DarioHealth Corp?
Based on the ratings of DarioHealth Corp's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.